Einat Brill Almon
2011
In 2011, Einat Brill Almon earned a total compensation of $367K as Senior Vice President, Product Development at Protalix BioTherapeutics, a 16% decrease compared to previous year.
Compensation breakdown
Option Awards | $32,557 |
---|---|
Salary | $263,357 |
Other | $71,074 |
Total | $366,988 |
Almon received $263.4K in salary, accounting for 72% of the total pay in 2011.
Almon also received $32.6K in option awards and $71.1K in other compensation.
Rankings
In 2011, Einat Brill Almon's compensation ranked 8,927th out of 10,747 executives tracked by ExecPay. In other words, Almon earned more than 16.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,927 out of 10,747 | 17th |
Division Manufacturing | 3,331 out of 3,960 | 16th |
Major group Chemicals And Allied Products | 845 out of 1,033 | 18th |
Industry group Drugs | 623 out of 781 | 20th |
Industry Biological Products, Except Diagnostic Substances | 113 out of 157 | 28th |
Source: SEC filing on October 9, 2014.
Almon's colleagues
We found four more compensation records of executives who worked with Einat Brill Almon at Protalix BioTherapeutics in 2011.
2011
David Aviezer
Protalix BioTherapeutics
Chief Executive Officer
2011
Tzvi Palash
Protalix BioTherapeutics
Chief Operating Officer
2011
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2011
Yossi Maimon
Protalix BioTherapeutics